Dr. Reddy's Laboratories Limited American Depositary Shares (RDY)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| $0.11 | 2003-08-07 | 2003-08-11 | |
| August 6, 2025 | $0.09 | 2025-07-25 | 2025-07-10 |
| August 12, 2024 | $0.48 | 2024-07-30 | 2024-07-15 |
| August 11, 2023 | $0.48 | 2023-07-28 | 2023-07-10 |
| August 12, 2022 | $0.38 | 2022-08-01 | 2022-07-11 |
Dividends Summary
- The most recent dividend was paid 45 days ago, on August 6, 2025
- The highest dividend payed out to investors during this period was $0.482608 per share
- The average dividend paid during this period was $0.24 per share.
Company News
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT
Alvotech, a global biotech company specializing in biosimilar medicines, will release its financial results for the first half of 2025 on August 14, 2025, via a webcast and conference call.
Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business
Dr Reddy's Laboratories reported a 16% increase in Q3 revenue, driven by its newly acquired Nicotine Replacement Therapy (NRT) portfolio and growth in emerging markets. The company's global generics revenue grew 17% year-over-year, with 7% growth excluding NRT contributions.
Dr. Reddy's (RDY) to Acquire Haleon's Nicotine Addiction Drug
Dr. Reddy's (RDY) is set to acquire Haleon's leading global NRT brand, Nicotinell, and its related portfolio across all formats of the drug for GBP 500 million to boost its OTC presence worldwide.
The success of Merck's antiviral — and other COVID-19 pills in development — may depend on how quickly people start taking them
That may mean starting treatment within days after testing positive for the virus.